Related Experiment Video
Updated: May 13, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities
Paloma Del C Monroig1, George A Calin
1Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston TX 77030, USA.
Abstract:
MicroRNAs (miRNAs) are a large family of post-transcriptional regulators of gene expression that control cellular and developmental processes by targeting messenger RNAs (mRNA). These small non-coding RNAs (ncRNAs) are aberrantly expressed in cancer, and are known to contribute to tumorigenesis and disease progression. Therapeutic strategies based on modulating miRNAs activity are emerging due to the ability of these ncRNAs to influence cellular behavior. MiRNA levels predict disease prognosis and overall patient survival, and reconstituting their basal levels has been proven to inhibit tumor growth and metastasis. Different delivery mechanisms have been tested in vivo, however many challenges need to be overcome before their utilization in the clinic. Moreover, it has been found that circulating miRNAs in body fluids have the potential to reshape cancer diagnosis and prognosis by functioning as biomarkers and indicators of progression and metastasis. These miRNAs as biofluids-based biomarkers provide an alternative strategy for early diagnosis and treatment of cancer patients.
Insights
MicroRNAs (miRNAs) are small molecules that regulate genes and are altered in cancer. Modulating miRNA activity offers therapeutic potential and circulating miRNAs show promise as cancer biomarkers for diagnosis and prognosis.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are key post-transcriptional gene regulators.
- Aberrant miRNA expression is linked to cancer development and progression.
- miRNAs influence cellular behavior and disease outcomes.
Purpose of the Study:
- To explore therapeutic strategies targeting miRNA activity in cancer.
- To investigate the role of miRNAs as prognostic and diagnostic biomarkers.
- To assess the potential of circulating miRNAs in body fluids for cancer management.
Main Methods:
- Review of current research on miRNA therapeutics and biomarkers.
- Analysis of studies investigating miRNA delivery mechanisms in vivo.
- Examination of circulating miRNA detection methods for cancer diagnosis.
Main Results:
- Modulating miRNA levels can inhibit tumor growth and metastasis.
- Circulating miRNAs in body fluids show potential as cancer biomarkers.
- Delivery of miRNA-based therapies faces clinical challenges.
Conclusions:
- miRNA-based therapies hold promise but require further development for clinical application.
- Circulating miRNAs represent a valuable tool for non-invasive cancer diagnosis, prognosis, and monitoring.
- Targeting miRNAs offers a novel approach to cancer treatment and management.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Microorganisms in Medicine and Therapeutics
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...

